Owner Active Biotech AB

Inventors Erlandsson, Eva; Walse, Bjorn; Antonsson, Per; Forsberg, Goran

Agent Davies Collison Cave

Pub. Number AU-B-2002315979

PCT Number PCT/SE02/01188

PCT Pub. Number WO2003/002143

Priority 0102327-4 28.06.01 SE

Filing date 19 June 2002

Wipo publication date 3 March 2003

Acceptance publication date 22 February 2007

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/085 (2006.01) Medicinal preparations containing antigens or antibodies - Staphylococcus

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/31 (2006.01) Peptides having more than 20 amino acids

C07K 14/315 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 (2006.01) Hybrid peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies